🏛️ Verified NIH Record • Updated 2026-05-21
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations (NCT05687188)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: H. Lee Moffitt Cancer Center and Research Institute
🩺 Plain-English Summary (8th-Grade Level)
This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (3 items) and avoid the listed exclusions (4 items).
Location: Moffitt Cancer Center — Tampa, Florida
Age range: 18 Years
🧪 Interventions in This Study
- Blood Sample Collection (OTHER)
- Tissue Sample Collection (OTHER)
- Data Collection (OTHER)
- Medical Image Collection (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Patient under 18 years of age
- Has no suspicion or diagnosis of a pancreatic cancer or tumor
- Self-reported race/ethnicity other than African American or Non-Hispanic White.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (2 Sites)
- Moffitt Cancer Center — Tampa, Florida
- University of Mississippi Medical Center — Jackson, Mississippi
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pancreatic Cancer
- A Study of Multiparametric Ultrasound Imaging Methods — Basking Ridge, New Jersey
- Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — Gilbert, Arizona
- Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions — Houston, Texas
- A Study of the Life Changes Experienced by Patients With Pancreatic Cancer — New York, New York
- Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma — Aurora, Colorado
Explore by condition: All Pancreatic Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.